-
The AI tools you use every day — Claude, ChatGPT, Gemini — are, in a meaningful sense, frozen in time. They learned everything they know during a multi-month training run, and then the learning stopped. New research published in 2025 and 2026 is attacking this problem from five different angles simultaneously. Here’s what’s actually working,…
-
SciPy 1.0 was published in February 2020. In the twelve months ending October 2025 it was cited 1,731 times. That is a five-year-old methods paper picking up roughly five new citations per day, with the rate still climbing. Its acceleration over the prior year is +94 per month, the third highest in the entire top-300…
-
Most “trending papers” lists are annual cuts: how many times a paper got cited this year versus last. That misses the shape of the curve. A paper that quietly clocked 200 citations evenly across twelve months looks identical to one that went from 5 per month to 40 per month. The second is actually taking…
-
In 2023 the European Society of Cardiology published its first comprehensive guideline on cardiomyopathies. OpenAlex has already logged more than 2,100 citations to that single document, a pace that puts it among the fastest-accelerating clinical papers of 2024. The guideline itself is not the story. The story is what it quietly codified: a drug class…
-
Steven Pinker’s Enlightenment Now proves that, on a 200-year baseline, almost everything is up and to the right. Peter Thiel’s The End of the Future argues that, since 1973, almost nothing in the physical world is. Both can be true. The trick is to plot each metric on its own longest available baseline and see…
-
Peter Thiel said in 2011 that the future had stalled. Ray Kurzweil said in 2005 that the future was on schedule. Reading both texts now, with a 9.3-million-patent corpus running underneath them, the answer is that they were arguing about different decades — and that the inflection between those decades happened, with disconcerting precision, the…
-
What started as a search for hidden innovation in medical devices turned into something bigger — a vision for how AI-driven R&D will need to coordinate across fields, and the infrastructure that doesn’t exist yet.
-
Kurzweil’s press-a-button cancer kill arrived — just not through the mechanism he predicted. Respirocytes and microbivores remain on paper.
-
Ten things Kurzweil said were already true in 2005, audited against 2026 evidence. The most-cited stat about the human body turns out to be wrong — in both directions.
-
Twenty-one years after Singularity Is Near, ten claims Kurzweil said were already true: what held up, what got overtaken, and the company whose path he rewrote.
-
The endocrine organ MicroCHIPS was supposed to ship by 2008 now rides a belt clip — while a May 2024 patent claims Kurzweil’s telomere-reset stem cells nearly word-for-word.
-
Kurzweil called the targets on medicine but missed the projectiles: wastewater not serum, mRNA not RNAi, senolytics not nanobots.
-
Twelve Kurzweil predictions about brain prosthetics, tested against the patents granted last quarter and the papers in NEJM from last October.
-
Kurzweil predicted diamondoid organs by the 2030s. What shipped is peptide drugs, living cells, and a titanium impeller on a magnetic field.
-
Ray Kurzweil’s 2005 medical predictions mostly reached their destinations — but almost never by the roads he named.
-
Twelve 2005 predictions on cell therapy, gene therapy, anti-amyloid vaccines, and diamondoid nanobots scored against 2026 clinical trials, patent filings, and approvals.
-
Twenty years after The Singularity Is Near, 3D NAND is everywhere, Nantero still hasn’t shipped, and the mesh lost to the cloud.